SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-13-369722
Filing Date
2013-09-18
Accepted
2013-09-18 06:06:32
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d550819d10k.htm 10-K 1018727
2 EX-23.1 d550819dex231.htm EX-23.1 1901
3 EX-31.1 d550819dex311.htm EX-31.1 10303
4 EX-31.2 d550819dex312.htm EX-31.2 10300
5 EX-32.1 d550819dex321.htm EX-32.1 3334
  Complete submission text file 0001193125-13-369722.txt   12343746

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT meip-20130630.xml EX-101.INS 780460
7 XBRL TAXONOMY EXTENSION SCHEMA meip-20130630.xsd EX-101.SCH 56906
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE meip-20130630_cal.xml EX-101.CAL 49960
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE meip-20130630_def.xml EX-101.DEF 302526
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20130630_lab.xml EX-101.LAB 461675
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20130630_pre.xml EX-101.PRE 347342
Mailing Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-50484 | Film No.: 131102576
SIC: 2834 Pharmaceutical Preparations